Search

Your search keyword '"Salminen, Kimmo"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Salminen, Kimmo" Remove constraint Author: "Salminen, Kimmo"
22 results on '"Salminen, Kimmo"'

Search Results

2. Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice

3. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)

5. LBO-03 - A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)

7. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

8. High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

9. Maahanmuutto 2020 –seminaari

10. High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).

11. Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

12. 1054 Elevated Fecal Calprotectin Predicts Relapse in Inflammatory Bowel Disease Patients After Stopping TNFα-Blocking Agents

13. Outcome After Discontinuation of TNFα-blocking Therapy in Patients with Inflammatory Bowel Disease in Deep Remission

14. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin

15. Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission?

21. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

22. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study.

Catalog

Books, media, physical & digital resources